RNA splicing during terminal erythropoiesis

Area of Science:

• Molecular Biology
• Hematopoiesis
• Gene Regulation

Background:

• Erythroid progenitors undergo significant cellular remodeling and gene expression changes during terminal erythropoiesis.
• Alternative splicing is a critical post-transcriptional mechanism regulated by RNA binding proteins and cis-regulatory motifs.
• Understanding splicing in erythroblasts is crucial for comprehending red blood cell development and associated diseases.

Purpose of the Study:

• To review recent studies defining the genome-wide scope of alternative splicing in erythroblasts.
• To discuss the regulation of alternative splicing during terminal erythropoiesis.
• To highlight the role of splicing in normal red blood cell production and in hematopoietic disorders.

Main Methods:

• RNA sequencing (RNA-seq) of highly purified erythroblast populations.
• Analysis of stage-specific splicing transitions during erythropoiesis.
• Review of studies linking splicing defects to myelodysplastic syndromes.

Main Results:

• Extensive alternative splicing of both exons and introns occurs in erythroblasts.
• Stage-specific splicing events generate protein isoforms vital for red blood cell production.
• Deficiencies in splicing regulators disrupt the erythroid splicing program, contributing to hematopoietic diseases like myelodysplastic syndromes.

Conclusions:

• Erythroid progenitors utilize an elaborate alternative splicing program to regulate gene expression and protein function during differentiation.
• This program ensures the synthesis of appropriate protein isoforms for mechanically stable red blood cells.
• Dysregulation of splicing by mutations or deficiencies in regulatory proteins causes disease.